5 November 2015
Neuroendocrine tumors (NETs) is the umbrella term for a group of unusual, often slow growing cancers, which develop from cells in the diffuse endocrine systems. They are found most commonly in the lung or gastrointestinal system, but they can arise in other parts of the body, such as the pancreas, ovary and testes, among other sites.
Neuroendocrine tumour awareness day is an annual, awareness-raising event coordinated by the International Neuroendocrine Cancer Alliance and takes place this year on Tuesday 10 November. As part of celebrating the day we would like to invite you to take part in a web chat on advances in NET medicine with Dr Christos Toumpanakis (pictured), consultant in gastroenterology and neuroendocrine tumours. Dr Toumpanakis will be online on 10 November at 2pm to answer your questions.
The web chat is free to attend and does not require registration, all you need to do is visit our NET web chat page at 2pm on 10 November.
Shortly before the webinar, we will be uploading a short video. The video shows Professor Martyn Caplin, clinical lead of the NET unit and professor of gastroenterology and GI neuroendocrinology; Professor Tim Meyer, consultant medical oncologist; Dr Christos Toumpanakis, consultant in gastroenterology and neuroendocrine tumours; and Dr Shaunak Navalkissoor, consultant in nuclear medicine, discussing some of the recent advances in NET medicine. Feel free to visit the page early to watch the video.
Web chats are a great way of asking our experts questions and getting an answer in real time. Dr Christos Toumpanakis will be answering questions via the web chat for one hour so get your questions ready. Once the web chat is underway, just type your question into the box provided. Please be aware that your question might not appear on the screen straight away.
Notes to editors
Media contacts: email@example.com or call 020 7317 7740
About the Royal Free London NHS Foundation Trust
The Royal Free began as a pioneering organisation and continues to play a leading role in the care of patients. Our mission is to provide world class expertise and local care. In the 21st century, the Royal Free London continues to lead improvements in healthcare.
The Royal Free London attracts patients from across the country and beyond to its specialist services in liver, kidney and bone marrow transplantation, haemophilia, renal, HIV, infectious diseases, plastic surgery, immunology, vascular surgery, cardiology, amyloidosis and scleroderma and we are a member of the academic health science partnership UCLPartners.